Even though Wessely and White have been cited as examples. And again in any case there's the casual incorrect premise: that Dr Mikovits science is being "discredited because of social skills" although as so often it's not clear who exactly you're saying, or implying, is doing this.
the way the words are actually used does not make sense - and sometimes they are used in a scientifically technically inaccurate way - so awol is in a way right and one can say "well we call HIV the HIV virus - or indeed the AIDS virus - when there are lots of strains" - but that is a shorthand, and no such term exists at present - certainly not 'XMRV' which falsely implies xenotropism, and who knows whether we will eventually call it, in common language, the HGRV virus, or something similar. For now though, it's a family of gammaretroviruses.
... I think this whole confusion is artificially created, and this confusion was immediately what I saw when I read the press release, which disappointed me for that reason because these complexities and arguments were immediately foreseeable. It was immediately obvious that this was a confirmation and extension of the WPI's work that had issues of detail that would dress the whole thing up as less important than it is. .. which just happens to downplay the story in the public spotlight in just the way one would predict that information with such massive implications would be handled.
As always, you exaggerate everything into a falsehood - "refusal to use Mikovits' word as a credible source" - refusal? - I don't even know but knowing your pattern my guess is because there wasn't a Mikovits quote in the article, maybe?The attacks in the article to which I refer are when he claimed that if the results conflict, the WPI must be wrong, the refusal to use Mikovits' own words as a credible source, etc.
Pure insanity. "Four viruses?" is now a factual error. Unbelievable.The title is simply a factual error. Alter also called Hep C and HIV "families of viruses". This does not change the fact that we still understand them and refer to them as single viruses when we speak of them.
"4 viruses?"The science is simply not there yet to declare these to be anything except variants. While words are not perfect, this is what we have to represent ideas. When we talk about having a virus, we say we have a certain one. Scientists can talk all they want about families of viruses and variants and strains etc. That does not change the fact that the title seems, because of the way we non-scientists use language, to be talking about big differences, like Hep C versus HIV versus H1N1, when really we are talking about minute differences that normally would have no role in popular perceptions of their virus. That is why the title is inaccurate and misleading.
Sorry - that would be the "XMRV and MLV related-viruses Conference".
Maybe y'all could take this argument off the public forum, e-mail privately back and forth or something? I'm looking for useful, hopefully uplifting information about my illness, and the interpersonal vitriol is stressing me and making me feel worse. Surely the crimes of simplification and misinterpretation committed in the press far outweigh what you are arguing about here?
Please? :worried:
I believe you just called Weesely and White brilliant scientists!
I would like to point out, yet again, for something like the 100th time, that I have not attacked Cort. I have attempted to explain why people are frustrated with him.
No you haven't, and you provide no evidence.I would be glad to. However as I have been falsely accused of saying things I did not say in public, my refutation of these claims would serve no purpose in private.
It means that it makes a big statement about how different the cohorts are. Lo/Alter find 85% (really 86% but let's not quibble) in the Komaroff et al samples but 0% in the CDC samples - suggests the CDC are picking different sorts of "CFS" patients.What the heck does this mean?Cort said:I think that would be an amazing finding - to go from 85% with MLV's to none - that would REALLY say something.
Dolphin said:Additionally, the CDC laboratory provided 82 samples from their published negative study to FDA, who tested the samples blindly. Initial analysis shows that the FDA test results are generally consistent with CDC, with no XMRV-positive results in the CFS samples CDC provided (34 samples were tested, 31 were negative, 3 were indeterminate)
He said:
That is so close! Does he actually say there were no MLV's in the population? Can you try to pin him down one more time specifically on the MLV's.The primer sets we used for studying CDC samples were the same ones published in our paper. The primer sets should amplify both XMRV and MLV-related virus gene sequences we identified in our PNAS study.
I think that would be an amazing finding - to go from 85% with MLV's to none - that would REALLY say something.
so I don't want to write to him again.Dear Dr. Lo,
Thank you for your reply.
I will not take up any more of your time to ask you more questions.
In case you're interested, I'm attaching a letter I had published in
Psychosomatic Medicine challenging the method the CDC are using to
pick their CFS patients.
Further information on the problems with the defintion have been
published by Prof. Leonard Jason and team since I wrote that.
Also, even before this empiric criteria (that was used to chose the
patients in the Switzer study), their community sampling were picking
out high functioning, not very ill patients e.g.
http://www.hqlo.com/content/1/1/48 (despite the name, these aren't the
same patients used in the Switzer study - it's a long story).
Also, the exclusions they use such as the Romberg test, may actually
exclude some of the "proper" CFS patients particularly the more ill
patients.
Dear Dr. Lo,
Just a moment of your time please.
I believe that the CDC are not choosing their CFS patients in a good
way but like to have my facts straight.
I posted the comment below on the Switzer et al paper based on my
initial reading of the information on the FDA website.
However one person has pointed out that maybe you only tested for XMRV
and not the MLVs you found in the paper?
I don't expect a long answer as I'm sure you're a busy man.
http://www.pnas.org/content/early/2010/08/16/1007944107.full.pdf+html
May I point to the editorial by Valerie Courgnauda, Jean-Luc Battinia, Marc Sitbona, and Andrew L. Mason
In Fig 1 XMRV is depicted as a hybride.
They write: Indeed, XMRV genomes (1, 2) are actually hybrids between polytropic endogenous MLV sequences for their 5′ half up to approximately the middle of pol and xenotropic MLV for their 3′ half that harbors env. The glycogag leader of XMRV matches 100% of a polytropic endogenous sequence of the 129 1/SvJ laboratory mouse strain (accession no. AAHY01591888.1), a commonly used strain for gene knock-outs in embryonic stem cells. However, the glycogag/gag sequences reported by Lo et al. (6) best match endogenous polytropic sequences of the C57BL/6J laboratory strain of Mus musculus, with 99% nucleotide homology, and the env sequences share 97% homology with similar endogenous polytropic MLV and mink cell focus-forming viruses. Env cross-dressing between different MLV, known as pseudotyping, is a common feature in dually infected hosts (19),allowing MLV to extend their original tropism. Indeed, the multiple origins of these xenotropic sequences, the hybrid nature of the XMRV genome, and the occlusion of the otherwise necessary glycogag ORF underscore the potential complementation and recombinational events that may lead to their transmission into humans.
The current data suggest that a variety of xenotropic and polytropic MLV can be found in North Americans with and without disease. To add to this bewilderment, it is likely that more than one environmental agent impacts on the development of both CFS and prostate cancer.
It means that it makes a big statement about how different the cohorts are. Lo/Alter find 85% (really 86% but let's not quibble) in the Komaroff et al samples but 0% in the CDC samples - suggests the CDC are picking different sorts of "CFS" patients.
''Further, the samples from these three study cohorts were collected using different types of tubes, each of which has a distinct way of being processed. As if this werent bad enough, none of the blood tubes used were of the same type used in the Lombardi study. (They used tubes containing sodium heparin that are intended for use with virus isolation). The blood tubes from the 18 Georgia registry patients are designed to collect whole blood and preserve nucleic acid; it is not clear where the plasma came from for these subjects since plasma cannot be obtained using these blood tube types. So the explanation for not finding XMRV in these samples is simple this was a study designed to not detect XMRV using a hodge-podge sample set.''
I emailed her asking her to look at the XMRV article I wrote and we talked and she told me that.
I think you have missed the point I was making.Hi Dolphin. Now about the negative CDC XMRV paper, anyone who has read it and analyzed it knows it's a joke. I can see you haven't read it or you'd know.
Additionally, the CDC laboratory provided 82 samples from their published negative study to FDA, who tested the samples blindly. Initial analysis shows that the FDA test results are generally consistent with CDC, with no XMRV-positive results in the CFS samples CDC provided (34 samples were tested, 31 were negative, 3 were indeterminate).
The more natural thing to assume I think is that they were doing the same testing, not XMRV-specific testing.Thanks. It sounds like he said they did. I emailed Dr. Alter about it but he hasn't answered me.